Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Featured News
May 23, 2018
Featured News
May 22, 2018
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community